Compare BHC & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHC | TBBK |
|---|---|---|
| Founded | N/A | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 1996 | 2005 |
| Metric | BHC | TBBK |
|---|---|---|
| Price | $5.36 | $52.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.33 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 2.5M | 523.0K |
| Earning Date | 05-18-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | 14.69 |
| EPS | 0.42 | ★ 4.92 |
| Revenue | ★ $8,724,000,000.00 | $141,147,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | N/A | $11.90 |
| P/E Ratio | $12.85 | ★ $10.83 |
| Revenue Growth | N/A | ★ 20.85 |
| 52 Week Low | $4.28 | $40.51 |
| 52 Week High | $8.69 | $81.65 |
| Indicator | BHC | TBBK |
|---|---|---|
| Relative Strength Index (RSI) | 32.81 | 37.19 |
| Support Level | N/A | $49.11 |
| Resistance Level | $7.22 | $53.83 |
| Average True Range (ATR) | 0.22 | 2.43 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 19.07 | 26.21 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.